[Special Edition: March 2020] Pill splitting: Making the most of meds in a time of need
Français | Español | Português | 繁體中文 | 简体中文 Clinical vignette A 54 year-old mechanic with type 2 diabetes and hypertension had a myocardial infarction in 2015. He currently takes ASA 81mg/d (over the counter) plus 6 generic prescription drugs dispensed monthly: atorvastatin 40mg/d ramipril 5mg/d empagliflozin 25mg/d escitalopram 10mg/d sildenafil 50mg 4 times/month … [Read more...]
Acetaminophen vs. NSAIDs during COVID-19 pandemic
TREATING FEVER AND PAIN in the time of COVID-19 Many people are asking doctors for information about whether it is safe to use NSAID drugs now. Examples of this drug class include ibuprofen (generic, Advil, Motrin), naproxen (generic, Aleve), diclofenac (generic, Voltaren, Arthrotec), celecoxib (Celebrex), meloxicam (Mobicox) and many others. Feeling an increase in your body temperature can … [Read more...]
[VIDEO] Pill splitting: Making the most of meds in a time of need
New Publications from the TI PharmacoEpidemiology Group
We are highlighting 2 recent articles published by members of the PharmacoEpidemiology Group (PEG) of the Therapeutics Initiative: Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System … [Read more...]
[Edição Especial Março 2020] Fracionamento de comprimidos: aproveitando ao máximo as medicações em tempos de necessidade
English | Français | Español | 繁體中文 | 简体中文 Vinheta clínica Um mecânico de 54 anos com diabetes tipo 2 e hipertensão teve um infarto do miocárdio em 2015. Ele toma atualmente 81 mg de aspirina (venda sem receita) mais 6 drogas genéricas dispensadas mensalmente: atorvastatina 40mg/d ramipril 5mg/d empagliflozina 25mg/dia escitalopram 10mg/d sildenafil 50mg 4 vezes/mês … [Read more...]
药片分割：在有需要的时候充分利用药物
繁體中文 | English | Français | Español | Português 模拟案例 一名患有二型糖尿病的54岁技工在2015年心脏病发作。 现在，他服用的药物包括: 阿托伐他汀(Atorvastatin) 40毫克/天 雷米普利 (Ramipril) 5毫克/天 阿司匹林 (Aspirin) 81毫克/天 (非处方药) 恩帕列净 (Empagliflozin) 25毫克/天 依他普仑 (Escitalopram) 10毫克/天 西地那非 (通用品牌伟哥) (Sildenafil)每月四次50毫克 度洛西汀(Duloxetine) 90毫克/天 他能全职工作并且身体状况一直稳定，但由於他刚被解雇，女儿的餐馆又结业了，因此他担心可能无法支付药物治疗的费用。 … [Read more...]
藥片分割：在有需要的時候充分利用藥物
简体中文 | English | Français | Español | Português 模擬案例 一名患有二型糖尿病的54歲技工在2015年心臟病發作。 現在，他服用的藥物包括: 阿托伐他汀(Atorvastatin) 40毫克/天 雷米普利 (Ramipril) 5毫克/天 阿司匹林 (Aspirin) 81毫克/天 (非處方藥) 恩帕列淨 (Empagliflozin) 25毫克/天 依他普侖 (Escitalopram) 10毫克/天 西地那非 (通用品牌偉哥) (Sildenafil)每月四次50毫克 度洛西汀(Duloxetine) 90毫克/天 他能全職工作並且身體狀況一直穩定，但由於他剛被解雇，女兒的餐館又結業了，因此他擔心可能無法支付藥物治療的費用。 … [Read more...]
[124] Your views of the Therapeutics Initiative: 2019 Survey
In 2019, the Therapeutics Initiative completed its fifth readership survey to evaluate perceptions of our academic unit and the impact of TI events. We conducted similar surveys in 1996, 2000, 2006, and 2011. In 2019 we invited a 10% random sample of all registered pharmacists in British Columbia (N=588) and a 10% random sample of physicians who receive our letter by mail (N=643) to participate in … [Read more...]
[Mar 25] Methods Speaker Series: Basics of Patient-Oriented Research: A case study in Patient Engagement in Transplant Research
TI Methods Speaker Series This event is over. Registration is now closed. Scroll down to view a video recording of this event. Click here to view a list of all talks offered in 2020 as part of the TI Methods Speaker Series. The TI Methods Speaker Series are offered free of charge and everyone is welcome, but space is limited, registered participants will be given priority. The event is usually … [Read more...]
Everyone Poops: What to Do When They Don’t
Dr. Jessica Otte, MD gave this presentation on October 5th, 2019 in Vancouver, BC at the "Bringing Best Evidence to Clinicians" medical education conference marking the 25th anniversary of the UBC Therapeutics Initiative. Dr. Otte is a Clinical Assistant Professor with the UBC Department of Family Practice, member of the Education Working Group of the UBC Therapeutics Initiative, and a family … [Read more...]
- 1
- 2
- 3
- …
- 27
- Next Page »
